Next-generation sequencing may challenge antibody patent claims

Next-generation sequencing may challenge antibody patent claimsNext-generation sequencing may challenge antibody patent claims, Published online: 09 May 2018; doi:10.1038/d41586-018-05065-5Next-generation sequencing may challenge antibody patent claims

Source: Nature AOP - May 9, 2018 Category: Research Authors: Prabakaran Ponraj Source Type: research